ADC Therapeutics SA (ADCT) said Jay Feingold, Senior Vice President and Chief Medical Officer, will depart the company. Joseph Camardo will be appointed Senior Vice President and Chief Medical Officer. Camardo joined the company from Celgene Corporation, where he was most recently Senior Vice President of Celgene Global Health.
"Camardo worked closely with Feingold for the last 18 months and together they ensured our first marketed product was well-received by the physician community in the United States and beyond," said Chris Martin, CEO.
Based in Lausanne (Biople), Switzerland, ADC Therapeutics has operations in London, the San Francisco Bay Area and New Jersey.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.